|
|
News Breaks | | | | December 27, 2012 | | 09:18 EDT |  | RDHL | RedHill Biopharma announces NASDAQ listing under symbol 'RDHL'
RedHill Biopharma reported the listing of the Company's ADS's on the Nasdaq Capital Market, following SEC and NASDAQ final approvals. | |
|
News For RDHL From The Last 14 Days Check below for free stories on RDHL the last two weeks. |
|
|
| June 18, 2013 | | 06:08 EDT | | RDHL | FDA accept NDA for RHB-103 developed by RedHill Biopharma and IntelGenx
 Subscribe for More Information | | | June 5, 2013 | | 07:11 EDT | | RDHL | RedHill Biopharma commences patient screening in Phase IIa trial with RHB-104
RedHill Biopharma announced that patient screening has commenced in the Phase IIa, proof of concept, clinical study, to assess the efficacy and safety of fixed dose combination RHB-104, a patent protected combination therapy of three antibiotics in a single capsule, as an add-on therapy to interferon beta-1a in patients treated for Relapsing Remitting Multiple Sclerosis. The phase IIa CEASE-MS Study follows the successful completion of four pre-clinical studies with RHB-104. | |
|
|
|
|
|
|
